FR2872289B1 - Utilisation de la proteine g5 dans le diagnostic in vitro d'infection a legionella pneumophila - Google Patents

Utilisation de la proteine g5 dans le diagnostic in vitro d'infection a legionella pneumophila

Info

Publication number
FR2872289B1
FR2872289B1 FR0407114A FR0407114A FR2872289B1 FR 2872289 B1 FR2872289 B1 FR 2872289B1 FR 0407114 A FR0407114 A FR 0407114A FR 0407114 A FR0407114 A FR 0407114A FR 2872289 B1 FR2872289 B1 FR 2872289B1
Authority
FR
France
Prior art keywords
protein
legionella pneumophila
vitro diagnosis
pneumophila infection
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0407114A
Other languages
English (en)
Other versions
FR2872289A1 (fr
Inventor
Jean Philippe Arie
Camille Cyncynatus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Claude Bernard Lyon 1 UCBL
Diaxonhit SA
Original Assignee
Universite Claude Bernard Lyon 1 UCBL
Abag SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Claude Bernard Lyon 1 UCBL, Abag SA filed Critical Universite Claude Bernard Lyon 1 UCBL
Priority to FR0407114A priority Critical patent/FR2872289B1/fr
Priority to DE602005016417T priority patent/DE602005016417D1/de
Priority to EP05778861A priority patent/EP1769249B1/fr
Priority to AT05778861T priority patent/ATE441865T1/de
Priority to PCT/FR2005/001548 priority patent/WO2006010805A2/fr
Publication of FR2872289A1 publication Critical patent/FR2872289A1/fr
Application granted granted Critical
Publication of FR2872289B1 publication Critical patent/FR2872289B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0407114A 2004-06-29 2004-06-29 Utilisation de la proteine g5 dans le diagnostic in vitro d'infection a legionella pneumophila Expired - Fee Related FR2872289B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0407114A FR2872289B1 (fr) 2004-06-29 2004-06-29 Utilisation de la proteine g5 dans le diagnostic in vitro d'infection a legionella pneumophila
DE602005016417T DE602005016417D1 (de) 2004-06-29 2005-06-21 Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
EP05778861A EP1769249B1 (fr) 2004-06-29 2005-06-21 Nouveaux polypeptides pour la mise en évidence in vitro et la prévention des infections à legionella pneumophila
AT05778861T ATE441865T1 (de) 2004-06-29 2005-06-21 Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
PCT/FR2005/001548 WO2006010805A2 (fr) 2004-06-29 2005-06-21 Nouveaux polypeptides pour la mise en evidence in vitro et la prevention des infections a legionella pneumophila

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0407114A FR2872289B1 (fr) 2004-06-29 2004-06-29 Utilisation de la proteine g5 dans le diagnostic in vitro d'infection a legionella pneumophila

Publications (2)

Publication Number Publication Date
FR2872289A1 FR2872289A1 (fr) 2005-12-30
FR2872289B1 true FR2872289B1 (fr) 2006-09-22

Family

ID=34945668

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0407114A Expired - Fee Related FR2872289B1 (fr) 2004-06-29 2004-06-29 Utilisation de la proteine g5 dans le diagnostic in vitro d'infection a legionella pneumophila

Country Status (1)

Country Link
FR (1) FR2872289B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610203D0 (en) * 1986-04-25 1986-05-29 Technology Licence Co Ltd Monoclonal antibodies
WO1999064610A1 (fr) * 1998-06-11 1999-12-16 St. Jude Children's Research Hospital Zmpb, nouveau determinant de la virulence de streptococcus pneumoniae, vaccin obtenu a partir de celui-ci et utilisations de ceux-ci

Also Published As

Publication number Publication date
FR2872289A1 (fr) 2005-12-30

Similar Documents

Publication Publication Date Title
FR24C1004I1 (fr) Formes galéniques de ganaxolone et procédés de preparation et d'utilisation de celles-ci
WO2005027733A3 (fr) Marqueurs biologiques destines au diagnostic de la sclerose en plaques
IL172507A0 (en) New biological entities and the pharmaceutical or diagnostic use thereof
DE602005002413D1 (de) Wegwerfhöschen
MA28844B1 (fr) Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol
FR2965484B1 (fr) Utilisation de nanoparticules metalliques dans le diagnostic de la maladie d'alzheimer
NO20054662D0 (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
AU2001291225A1 (en) Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients
FR2895519B1 (fr) Utilisation de la proteine 5e2 dans le diagnostic in vitro d'infection a legionella pneumophila
FR2872289B1 (fr) Utilisation de la proteine g5 dans le diagnostic in vitro d'infection a legionella pneumophila
DK1461042T3 (da) Anvendelse af desoxypeganin til behandling af klinisk depression
ITMI20040124A1 (it) Macrolidi ad attivita' antiinfiammatoria
FR2908890B1 (fr) Utilisation de la proteine 5g1 dans le diagnostic in vitro d'infections a staphyloccus aureus et/ou epidermidis
FR2874009B1 (fr) Utilisation d'alcoxybenzenes comme agent stimulateur sanguin
FR2922648B1 (fr) Utilisation de la proteine 8c2 pour le diagnostic in vitro d'infections a mycoplasma pneumoniae
FR2902015B1 (fr) Adaptateur pour valve d'introducteur dans le corps humain ou animal
UA10191S (uk) Етикетка медичного препарату «ксилат»
JP2005232659A5 (fr)
ITMO20060009U1 (it) Organizer attivita' professionali
FR2869603B1 (fr) Unite de traitement d'effluent
ITMC20040042A1 (it) Cerchio semovente con l'aiuto delle due spinte del fulcro antireattive del braccio corto negativo.
FR2838350B1 (fr) L'acide lactique directement dans l'intestin
HU0400903D0 (en) Use of genes as molecular markers in diagnosis of schizophrenia and diagnostic kit for the same
WO2004062462A3 (fr) Anticorps monoclonaux de la proteine gw182 de liaison a l'arn
UA10705S (uk) Чобітки жіночі

Legal Events

Date Code Title Description
AU Other act affecting the ownership or exploitation of an industrial property right
CD Change of name or company name
TQ Partial transmission of property

Owner name: UNIVERSITE CLAUDE BERNARD LYON I, FR

Effective date: 20150202

Owner name: DIAXONHIT, FR

Effective date: 20150202

PLFP Fee payment

Year of fee payment: 13

ST Notification of lapse

Effective date: 20180228